Simoni, Graham, and Colleagues Examine Product and Delivery Attributes Related to Acceptability and Feasibility of HIV Treatment in Kenya
Posted: 5/2/2024 (CSDE Research)
CSDE Affiliates Jane M. Simoni (Psychology) and Susan M. Graham (Medicine and Global Health) released research with colleagues in BMC Infectious Diseases, entitled “Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya“. In 2020, 14% of diagnosed persons living with HIV (PLWH) in Kenya were not taking antiretroviral therapy (ART), and 19% of those on ART had unsuppressed viral loads. Long-acting antiretroviral therapy (LA-ART) may increase viral suppression by promoting ART uptake and adherence. Authors conducted key informant (KI) interviews with HIV experts in Kenya to identify product and delivery attributes related to the acceptability and feasibility of providing LA-ART to PLWH in Kenya.